Len Paolillo

Bio:

Len Paolillo is the President of Merz Therapeutics North America. He leads the commercial strategy and execution of the organization’s expanding product portfolio across the U.S. and Canada businesses, while furthering Merz Therapeutics’ commitment to bringing better outcomes for more patients.

Len has more than two decades of extensive experience in both start-up and global biopharmaceutical sectors. Most recently, he served as the Chief Commercial Officer and subsequently as the Interim President and Chief Executive Officer of Impel Pharmaceuticals, where Len was instrumental in shaping and executing the corporate, product and commercial strategies. Prior, he was the Executive Vice President and Chief Commercial Officer at Kyowa Kirin Inc., the North American affiliate of Kyowa Kirin Co. Ltd. In this role, Len spearheaded the growth and transformation of the commercial infrastructure, enabling the successful launches of the company’s pipeline products in hematology/oncology, central nervous system and rare disease. Earlier in his career, Len served as senior director of sales at Warner Chilcott Pharmaceuticals.

Len holds a Bachelor of Science in Business Administration from Manhattan College. He lives in New Jersey with his wife, three boys and family dog, and they can often be found rooting for their favorite New York sports teams.